GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Respiratory market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Respiratory market reports here.

NEW Acute Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Acute Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Lung Injury pipeline landscape. The report provides comprehensive...

NEW Allergic Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Allergic Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Allergic Asthma pipeline landscape. The report provides comprehensive information on...

NEW Emphysema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Emphysema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Emphysema pipeline landscape. The report provides comprehensive information on the therapeutics...

NEW Chronic Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Chronic Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chronic Bronchitis pipeline landscape. The report provides comprehensive information on...

NEW Chronic Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Chronic Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chronic Cough pipeline landscape. The report provides comprehensive information on...

NEW Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Hypoxia pipeline landscape. The report provides comprehensive information on the therapeutics...

NEW Lung Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Lung Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lung Disease pipeline landscape. The report provides comprehensive information on...

NEW Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Pulmonary Inflammation pipeline landscape. The report provides comprehensive information on...

NEW Respiratory Depression (Hypoventilation) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Respiratory Depression (Hypoventilation) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Respiratory Depression (Hypoventilation) pipeline landscape. The report provides comprehensive...

NEW Seasonal Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Seasonal Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Seasonal Allergic Rhinitis pipeline landscape. The report provides comprehensive...